Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
SHANK3 Haploinsufficiency: early-phase trial registry
1 of 1 indexed SHANK3 Haploinsufficiency trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
SHANK3 Haploinsufficiency: 1 US clinical trial tracked, 1 recruiting.
SHANK3 Haploinsufficiency is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Jaguar Gene Therapy, running 1 of these trials.
Enrollment posture brief
Registry condition shank3-haploinsufficiency
OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
SHANK3 Haploinsufficiency lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for SHANK3 Haploinsufficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
SHANK3 Haploinsufficiency is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on SHANK3 Haploinsufficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on SHANK3 Haploinsufficiency trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this SHANK3 Haploinsufficiency page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 SHANK3 Haploinsufficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jaguar Gene Therapy sponsors the most SHANK3 Haploinsufficiency trials on record, review their full trial history before evaluating a specific study. See Jaguar Gene Therapy's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This SHANK3 Haploinsufficiency condition card totals 1 registered trials; most-linked intervention JAG201; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.